Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
21 May, 2019 16:43 IST
Alembic Pharma announces completion of USFDA inspection at Aleor Dermaceuticals
Source: IRIS | 12 Feb, 2019, 10.37AM
Comments  |  Post Comment

Alembic Pharmaceuticals announced that Aleor Dermaceuticals (Aleor), a 60:40 Joint Venture between Alembic Pharmaceuticals and Orbicular Pharmaceutical Technologies, has completed United States Food and Drug Administration (USFDA) inspection at its formulation manufacturing facility located at Karakhadi, Gujarat, India; with two observations.

The inspection was carried out from February 4, 2019 to February 8, 2019.

The stock had underperformed the market over the past one month till Feb. 11, 2019, falling 4.03% compared with the Sensex's 0.80% rise. It underperformed the market in past one quarter, declining 3.84% as against 3.52% rise in the Sensex.

Shares of the company declined Rs 9.9, or 1.75%, to trade at Rs 556.80. The total volume of shares traded was 1,524 at the BSE (3.55 p.m., Monday).

Alembic Pharmaceuticals Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Security Code type    into this box
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer